Any current/future new fundraising through debt or equity?

No explicit mention of any current or planned new fundraising through debt or equity in the transcript. The company discussed ongoing and planned capex, including INR2,300 crores for FY '27 on battery materials and around INR800 crores for the standalone chemical business. The cumulative capex guidance remains at INR6,000 crores over 4-5 years for the EV segment. Management highlighted capitalization of assets and funding ongoing expansions but did not specify raising fresh capital via equity or new debt. Existing projects appear funded through internal accruals or prior arrangements; no clear

Any current/future capex/capital investment/strategic investment?

INR 850 crores capex planned for FY '27 on chemical side: - INR 150 crores for expanding refrigerant gas (R-32) capacity to 20,000 tons. - INR 222 crores for new high-purity electronic specialty chemicals (semiconductor sector). - INR 250 crores for new fluoropolymer capacities (focusing on new fluoropolymers). - INR 230 crores on backward integration and maintenance. INR 2,300 crores capex planned for FY '27 on EV battery materials: - Capacity expansions across existing battery material products including LiPF6 salt and LFP cathode active material. - New natural graphite anode act

Future growth expectations in sales/revenue/volumes?

EBITDA growth is expected alongside volume growth, driven by higher margin products. (Page 15) Significant quarter-on-quarter revenue growth anticipated in battery chemicals, reaching a 3-digit crore exit rate by Q4 FY '27. (Page 15) Refrigerant (R-32) capacity ramp-up to 20,000 tons expected, with contracted sales and no selling challenges. Revenue growth to follow capacity scaling. (Page 14) Fluoropolymers business will see volume and EBITDA growth as capacity utilization approaches optimum and new higher-value polymers are added. (Page 14) Battery materials business ramping up with commerci

Future growth expectations in earnings/operating earnings/profits/EPS?

EBITDA growth is expected alongside volume growth due to higher-margin products (Page 15). Significant quarter-on-quarter revenue growth anticipated in the battery chemicals segment, reaching a three-digit crore exit rate by Q4 FY '27 (Page 15). Short to medium-term growth driven by refrigerant and fluoropolymer segments (Page 15). Medium to long-term growth driven by advanced battery materials business scaling up (Page 15). Fluoropolymers segment expected to continue volume and EBITDA growth with capacity ramp-up and addition of high-value polymers (Pages 13-14). Battery materials business to

Current/ Expected Orderbook/ Pending Orders?

All initial capacities under Phase One of the battery materials business have been commissioned and contracted for. Marquee anchor customers secured across all battery material products, providing confidence on utilization ramp-up. LiPF6 salt has approvals from most major global electrolyte players; commercial sales scaling in line with plans. Orders are in place for FY '27 and beyond, with production expected to ramp up quarter-on-quarter. Cathode active material samples received initial approval; final qualification expected by Q3 FY '27, with off-take agreements for entire capacity. The nat

IN US

Sale is live|00:00:00left today

Gujarat Fluorochemicals LtdQ1 FY26Chemicals & Petrochemicals

Gujarat Fluorochemicals Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹3,915P/E: 61.2Market Cap: ₹40.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→EBITDA growth is expected alongside volume growth, driven by higher margin products. (Page 15)
→Significant quarter-on-quarter revenue growth anticipated in battery chemicals, reaching a 3-digit crore exit rate by Q4 FY '27. (Page 15)
→Refrigerant (R-32) capacity ramp-up to 20,000 tons expected, with contracted sales and no selling challenges. Revenue growth to follow capacity scaling. (Page 14)
→Fluoropolymers business will see volume and EBITDA growth as capacity utilization approaches optimum and new higher-value polymers are added. (Page 14)
→Battery materials business ramping up with commercial sales starting for LiPF6 salt and cathode active materials; revenues to grow quarter-on-quarter. (Pages 12-13)
→Expected 15-20% growth in fluoropolymers volumes in FY '27, with pricing and volumes both increasing. (Page 9)
→Full earnings potential from battery materials investments expected by FY '29 with optimum utilization. (Page 5)

Margin guidance

Category 3

→EBITDA growth is expected alongside volume growth due to higher-margin products (Page 15).
→Significant quarter-on-quarter revenue growth anticipated in the battery chemicals segment, reaching a three-digit crore exit rate by Q4 FY '27 (Page 15).
→Short to medium-term growth driven by refrigerant and fluoropolymer segments (Page 15).
→Medium to long-term growth driven by advanced battery materials business scaling up (Page 15).
→Fluoropolymers segment expected to continue volume and EBITDA growth with capacity ramp-up and addition of high-value polymers (Pages 13-14).
→Battery materials business to realize full earnings potential by FY '29 as facilities ramp up and optimize utilization (Page 5).
→Capex of ~INR2,300 crores planned for FY '27 in battery materials with targeted EBITDA margins above 25% and asset turns of ~2x (Page 5).
→Chemicals business (excluding EV) shows steady-state EBITDA margins in line with prior expectations, with planned capex to support growth (Pages 9-10).

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→No explicit mention of any current or planned new fundraising through debt or equity in the transcript.
→The company discussed ongoing and planned capex, including INR2,300 crores for FY '27 on battery materials and around INR800 crores for the standalone chemical business.
→The cumulative capex guidance remains at INR6,000 crores over 4-5 years for the EV segment.
→Management highlighted capitalization of assets and funding ongoing expansions but did not specify raising fresh capital via equity or new debt.
→Existing projects appear funded through internal accruals or prior arrangements; no clear indications of upcoming fundraising events.

Order book

Yes

→All initial capacities under Phase One of the battery materials business have been commissioned and contracted for.
→Marquee anchor customers secured across all battery material products, providing confidence on utilization ramp-up.
→LiPF6 salt has approvals from most major global electrolyte players; commercial sales scaling in line with plans.
→Orders are in place for FY '27 and beyond, with production expected to ramp up quarter-on-quarter.
→Cathode active material samples received initial approval; final qualification expected by Q3 FY '27, with off-take agreements for entire capacity.
→The natural graphite anode active material facility is planned, further expanding product portfolio and order potential.
→For R-32 refrigerant, the current 10,000-ton capacity is commissioned and operating at optimal levels with contracts in place.
→The fluoropolymers business has contracts in some cases, both domestic and export, with confident volume ramp-up.
→Overall, orderbook visibility is strong across battery chemicals, refrigerants, and fluoropolymers segments.

Capex plans

Yes

→INR 850 crores capex planned for FY '27 on chemical side:
→ - INR 150 crores for expanding refrigerant gas (R-32) capacity to 20,000 tons.
→ - INR 222 crores for new high-purity electronic specialty chemicals (semiconductor sector).
→ - INR 250 crores for new fluoropolymer capacities (focusing on new fluoropolymers).
→ - INR 230 crores on backward integration and maintenance.
→INR 2,300 crores capex planned for FY '27 on EV battery materials:
→ - Capacity expansions across existing battery material products including LiPF6 salt and LFP cathode active material.
→ - New natural graphite anode active material facility.
→ - This is part of a cumulative INR 6,000 crores capex planned for battery materials by FY '28.
→Oman project capex proceeding as planned, unaffected by Middle East geopolitical issues.
→Further fluoropolymer investments planned as existing capacities near full utilization.
→Capex aims to achieve asset turns close to 2x and EBITDA margins above 25%, with full earnings potential by FY '29.

How does Gujarat Fluorochemicals Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Gujarat Fluorochemicals Ltd

Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Gujarat Fluorochemicals Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio